8158

HKSE:8158

China Regenerative Medicine International Limited

  • Stock

HKD

Last Close

0.16

22/07 07:24

Market Cap

48.68M

Beta: 1.79

Volume Today

250

Avg: 327.38K

PE Ratio

88.87

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '14
Apr '15
Apr '16
Apr '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
510K
-
2.82M
452.35%
27.75M
885.13%
356.99M
1,186.39%
72.95M
79.56%
47.97M
34.24%
185.34M
286.36%
282.90M
52.64%
231.61M
18.13%
69.49M
70.00%
cost of revenue
352K
-
1.43M
306.53%
9.41M
557.58%
219.46M
2,232.22%
45.95M
79.06%
19.05M
58.53%
140.33M
636.55%
215.17M
53.33%
193.99M
9.84%
50.06M
74.19%
gross profit
158K
-
1.39M
777.22%
18.34M
1,223.30%
137.53M
649.82%
27.01M
80.36%
28.92M
7.08%
45.01M
55.65%
67.73M
50.47%
37.62M
44.45%
19.42M
48.37%
selling and marketing expenses
66.80M
-
134.69M
101.65%
56.26M
58.23%
26.64M
52.65%
4.39M
83.51%
3.60M
17.94%
general and administrative expenses
136.88M
-
171.13M
25.02%
303.25M
77.21%
322.46M
6.34%
324.02M
0.48%
201.06M
37.95%
158.74M
21.05%
43.05M
72.88%
22.21M
48.41%
selling general and administrative expenses
136.88M
-
171.13M
25.02%
303.25M
77.21%
389.26M
28.36%
458.71M
17.84%
257.32M
43.90%
185.38M
27.96%
47.45M
74.41%
25.82M
45.59%
128.54M
397.87%
research and development expenses
16.33M
-
368K
97.75%
other expenses
5.66M
-
2.10M
62.89%
9.13M
334.55%
20.89M
128.85%
-22.27M
206.59%
-7.19M
67.70%
-4.37M
39.20%
-41.44M
847.63%
6.79M
116.39%
cost and expenses
137.23M
-
172.56M
25.74%
311.89M
80.75%
597.40M
91.54%
491.83M
17.67%
269.18M
45.27%
321.33M
19.38%
221.18M
31.17%
226.60M
2.45%
178.60M
21.18%
operating expenses
136.88M
-
171.13M
25.02%
302.48M
76.76%
377.94M
24.95%
445.88M
17.98%
250.13M
43.90%
181.01M
27.63%
6.01M
96.68%
32.61M
442.92%
128.54M
294.19%
interest expense
2.53M
-
3.06M
20.77%
25.83M
744.57%
24.43M
5.42%
21.65M
11.35%
5.34M
75.33%
18.52M
246.70%
736K
96.03%
781K
6.11%
979K
25.35%
ebitda
-242.25M
-
-179.06M
26.08%
-113.56M
36.58%
-144.11M
26.91%
-566.71M
293.25%
-172.45M
69.57%
-126.41M
26.70%
64.66M
151.15%
8.79M
86.41%
-97.80M
1,212.46%
operating income
-272.72M
-
-228.04M
16.38%
-165.45M
27.45%
-199.39M
20.52%
-636.41M
219.18%
-224.14M
64.78%
-128.14M
42.83%
64.59M
150.40%
8.62M
86.65%
-109.11M
1,365.81%
depreciation and amortization
30.46M
-
48.98M
60.77%
51.89M
5.95%
55.28M
6.53%
69.70M
26.09%
51.69M
25.84%
1.73M
96.65%
78K
95.49%
171K
119.23%
11.32M
6,518.13%
total other income expenses net
-2.53M
-
-44.49M
1,657.11%
-25.75M
42.12%
-11.53M
55.23%
-716.39M
6,113.78%
-232.50M
67.54%
-149.19M
35.84%
-294K
99.80%
-353K
20.07%
1.41M
500.57%
income before tax
-275.25M
-
-272.53M
0.99%
-191.20M
29.84%
-210.92M
10.31%
-1.35B
541.38%
-456.64M
66.24%
-277.33M
39.27%
64.29M
123.18%
8.27M
87.14%
-107.70M
1,402.76%
income tax expense
-3.95M
-
-17.14M
333.71%
3.33M
119.41%
-11.73M
452.62%
-68.88M
487.35%
-8.90M
87.08%
12.38M
239.09%
12.46M
0.69%
3.71M
70.22%
net income
-263.44M
-
-250.10M
5.07%
-190.90M
23.67%
-184.50M
3.35%
-1.19B
546.88%
-447.74M
62.48%
-289.71M
35.30%
51.83M
117.89%
4.55M
91.21%
-107.70M
2,464.41%
weighted average shs out
493.79M
-
620.13M
25.58%
865.47M
39.56%
879.37M
1.61%
879.29M
0.01%
87.93M
90.00%
160.68M
82.74%
285.43M
77.64%
285.43M
0%
286.41M
0.34%
weighted average shs out dil
493.79M
-
620.13M
25.58%
865.47M
39.56%
879.37M
1.61%
879.29M
0.01%
87.93M
90.00%
160.68M
82.74%
285.43M
77.64%
285.43M
0%
286.41M
0.34%
eps
-0.53
-
-0.40
24.53%
-0.22
45%
-0.21
4.55%
-1.36
547.62%
-5.09
274.26%
-1.80
64.64%
0.18
110.00%
0.02
91.11%
-0.38
2,475%
epsdiluted
-0.53
-
-0.40
24.53%
-0.22
45%
-0.21
4.55%
-1.36
547.62%
-5.09
274.26%
-1.80
64.64%
0.18
110.00%
0.02
91.11%
-0.38
2,475%

All numbers in HKD (except ratios and percentages)